Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | PDE7A | Q13946 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | TYMS | P04818 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.37 |
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | INPPL1 | O15357 | 1/20 | 0.37 |
| ▸ | DHFR | P00374 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | IDO1 | P14902 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11632286 | 0.80 | INPPL1 (0.35) | TDP1PDE7AALOX15MAPK1HSD17B10 | |
| SCHEMBL9367583 | 0.80 | TDP1 (0.48) | TDP1ALOX15MAPK1HSD17B10L3MBTL1 | |
| SCHEMBL30612243 | 0.80 | TDP1 (0.44) | TDP1ATMPDE7AMAPK1L3MBTL1 | |
| SCHEMBL21596680 | 0.80 | TDP1 (0.44) | TDP1ATMPDE7AMAPK1L3MBTL1 | |
| SCHEMBL30467812 | 0.80 | TDP1 (0.48) | TDP1ALOX15MAPK1HSD17B10L3MBTL1 | |
| SCHEMBL1582196 | 0.80 | MAP4K4 (0.49) | TDP1ATMPDE7AALDH1A1MAPT | |
| SCHEMBL30122384 | 0.78 | TDP1 (0.52) | TDP1ALOX15MAPK1ALDH1A1MAPT | |
| SCHEMBL10069071 | 0.78 | TDP1 (0.42) | TDP1ATMPDE7AMAPK1L3MBTL1 | |
| SCHEMBL986221 | 0.78 | TDP1 (0.52) | TDP1ALOX15MAPK1ALDH1A1MAPT | |
| SCHEMBL203312 | 0.78 | INPPL1 (0.46) | TDP1PDE7AALOX15MAPK1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116706237-B | Quick ion conductor additive, mixed electrolyte, sodium ion battery and vehicle | 浙江华宇钠电新能源科技有限公司 | 2023-12-15 | — | — | CN | claimed |
| US-20250388571-A1 | AMP-ACTIVATED PROTEIN KINASE MODULATOR COMPOUNDS AND USES THEREOF | BIOLEXIS THERAPEUTICS INC (US) | 2025-12-25 | — | — | US | disclosed |
| US-20240158385-A1 | NOVEL COMPOUNDS | Cerevance, Inc. | 2024-05-16 | — | — | US | disclosed |
| CN-116706237-B | Quick ion conductor additive, mixed electrolyte, sodium ion battery and vehicle | 浙江华宇钠电新能源科技有限公司 | 2023-12-15 | — | — | CN | disclosed |
| EP-4288433-A1 | NOVEL COMPOUNDS | Cerevance, Inc. (US) | 2023-12-13 | — | — | EP | disclosed |
| CN-116981665-A | Novel compounds | 思瑞万斯公司 | 2023-10-31 | — | — | CN | disclosed |
| CN-116706237-A | Quick ion conductor additive, mixed electrolyte, sodium ion battery and vehicle | 浙江华宇钠电新能源科技有限公司 | 2023-09-05 | — | — | CN | disclosed |
| WO-2023097187-A1 | AMPK ACTIVATORS | KALLYOPE, INC. (US) | 2023-06-01 | — | — | WO | disclosed |
| WO-2022167819-A1 | NOVEL COMPOUNDS | Cerevance, Inc. (US) | 2022-08-11 | — | — | WO | disclosed |
| US-10640488-B2 | Antibacterial compounds | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) | 2020-05-05 | — | — | US | disclosed |
| WO-2008009700-A1 | DERIVATIVES AND ANALOGS OF N-ETHYLQUINOLONES AND N-ETHYLAZAQUINOLONES | GLAXO GROUP LIMITED (GB) | 2008-01-24 | — | — | WO | disclosed |
| CN-1100056-C | Compound for inhibition of gastric acid secretion | ASTRA AB (SE) | 2003-01-29 | — | — | CN | disclosed |
| EP-0971920-B1 | COMPOUNDS FOR INHIBITION OF GASTRIC ACID SECRETION | ASTRAZENECA AB (SE) | 2002-06-05 | — | — | EP | disclosed |
| US-6265415-B1 | ANTIULCER AGENT | ASTRAZENECA AB (SE) | 2001-07-24 | — | — | US | disclosed |
| CN-1248257-A | Compound for inhibition of gastric acid secretion | ASTRA AB (SE) | 2000-03-22 | — | — | CN | disclosed |
| EP-0971920-A1 | COMPOUNDS FOR INHIBITION OF GASTRIC ACID SECRETION | Astra Aktiebolag (SE) | 2000-01-19 | — | — | EP | disclosed |
| WO-1998037080-A1 | COMPOUNDS FOR INHIBITION OF GASTRIC ACID SECRETION | ASTRA AKTIEBOLAG (SE) | 1998-08-27 | — | — | WO | disclosed |
| US-4087432-A | HERBICIDES | ELI LILLY AND COMPANY (US) | 1978-05-02 | — | — | US | disclosed |
| US-3968116-A | HERBICIDE | ELI LILLY AND COMPANY (US) | 1976-07-06 | — | — | US | disclosed |
| US-3963734-A | HERBICIDES, HERBICIDE INTERMEDIATES | ELI LILLY AND COMPANY (US) | 1976-06-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240158385-A1 | NOVEL COMPOUNDS | KCNK3, KCNA4, KCNK13 | TDP1 2297/4885ATM 3392/4885PDE7A 726/4885 |
| US-20250388571-A1 | AMP-ACTIVATED PROTEIN KINASE MODULATOR COMPOUNDS AND USES THEREOF | PRKAB2, PRKAB1, PRKAR2B | TDP1 2869/4885ATM 112/4885PDE7A 215/4885 |
| US-10640488-B2 | Antibacterial compounds | MRPL21, CLPP, NRDC | TDP1 4350/4885ATM 4441/4885PDE7A 4405/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.